Study to Investigate Safety, Pharmacokinetic (PK), Pharmacodynamic (PD) and Clinical Activity of Trametinib in Subjects With Cancer or Plexiform Neurofibromas and Trametinib in Combination With Dabrafenib in Subjects With Cancers Harboring V600 Mutations
Clinical trial NCT02124772 · COMPLETED
Trial details
- NCT number
- NCT02124772
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-15
- Primary completion
- 2020-12-29
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.